Oriola
  • Sustainability
  • People and career
  • Investors
  • Newsroom
  • Contact Us
  • Log in to Digital Services

  • About us
  • Distribution services

    • Distribution services
    • Pharmaceutical companies
      • Pharmaceutical companies
      • Vaccine distribution
      • Reporting and analytics
      • Warehousing and distribution
    • Pharmacies
      • Pharmacies
      • Distribution
      • Dose dispensing
      • Research pharmacies
      • Special licensed medicines
    • Veterinarians
      • Veterinarians
      • Special licensed medicines
      • Distribution
  • Wholesale services

    • Wholesale services
    • Health and wellbeing products
    • Become a supplier
  • Advisory services

    • Advisory services
    • Clinical Trials
    • Market access and tenders
    • Market entry and commercial services
    • Medical and regulatory affairs
    • Medical information and safety
    • Medical translations
    • Research services
    • Interim solutions
    • Suomi
  • Oriola as an investment
    • Strategy and targets
    • Business
    • Operating environment
    • Sustainable investment
    • Acquisitions and divestments
    • Analysts
  • Shares
    • Share price trend tool
    • Total return calculator
    • Dividend
    • Share capital and shares
    • Combination of share classes
  • Shareholders
    • Major shareholders
    • Flagging notifications
  • Reports and presentations
    • Annual Report
  • Financial information
    • Key figures
    • Reporting segments
    • Long-term targets
    • Outlook
    • Near-term risks and uncertainty factors
    • Accounting principles
  • Corporate Governance
    • Shareholder meetings
      • AGM 2025
      • AGM 2024
      • AGM 2023
      • AGM 2022
      • AGM 2021
      • AGM 2020
      • AGM 2019
      • AGM 2018
      • AGM 2017
      • AGM 2016
      • AGM 2015
      • AGM 2014
      • AGM 2013
      • AGM 2012
    • Shareholders’ Nomination Board
    • The Board of Directors
    • CEO and management
    • Remuneration
    • External Audit
    • Internal control
    • Risks
    • Insider register
    • Articles of Association
    • Shareholders' agreements
    • Disclosure Policy
  • Investor calendar
  • Investor relations
    • Subscribe to releases
  • Frontpage
  • Investors
  • Financial information

Reporting segments

Oriola's two reporting segments are Distribution and Wholesale.

Distribution segment 

  • Pharmaceutical logistics
  • Dose dispensing services

Wholesale segment

  • Wholesale of traded goods and over-the-counter (OTC) products
  • Parallel import
  • Special licensed medicines
  • Advisory services
Go to reports and presentations

Updated: 4 March 2025

Oriola

Contact us

Follow us

  • Linkedin
Log in to digital services
About us
Investors
Sustainability
Career
Newsroom

Oiva reports
Privacy policy
Copyright (C) 2006-2025